Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2022  |  Volume : 18  |  Issue : 79  |  Page : 651-658

Terfezia claveryi chatin: Anti-tumor effects against ehrlich solid tumor in mice


1 Department of Biology, College of Science and Humanities-Al Quwaiiyah, Shaqra University, Al Quwaiiyah 19257, Saudi Arabia
2 Department of Biology, Faculty of Applied Science, Umm Al-Qura University, Makkah, Saudi Arabia
3 College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia
4 Faculty of Science, Department of Biology, University of Tabuk, Tabuk 47913, Saudi Arabia
5 Department of Biology, Jamoum University College, Umm Al-Qura University, Makkah, Saudi Arabia

Correspondence Address:
Norah A Althobaiti
Department of Biology, College of Science and Humanities-Al Quwaiiyah, Shaqra University, Al Quwaiiyah 19257
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_12_22

Rights and Permissions

Background: Numerous reports on the side effects of anti-cancer drugs have encouraged scientists to search for alternative anti-cancer agents with higher efficacy and fewer side effects. The current investigation was intended to study the anti-tumor efficacy of Terfezia claveryi Chatin methanolic extract (TCME) on mice with Ehrlich solid tumors (EST). Materials and Methods: EST mice received TCME at doses of 50 and 100 mg/kg orally once a day for two weeks. To study the anti-tumor effects, the rate of tumor growth, weight of the body, the serum level of some tumor markers, enzymes related to liver and kidney function, oxidant and antioxidant enzymes, tumor necrosis factor alpha (TNF-α) level, and some genes related to apoptosis were investigated. Results: The results revealed that the growth rate of the tumor, tumor markers, oxidative markers, enzymes related to liver and kidney function, level of TNF-α, and Bcl-2 gene expression were considerably declined in the EST mice receiving the TCME, whereas the enzyme levels related to antioxidant activity as well as Bax and caspase-3 gene expression were considerably elevated (P < 0.001). Conclusion: We found that T. claveryi methanolic extract has relevant anti-tumor efficacy on mice with EST and might be considered as a substitute anti-cancer compound; however, more studies especially in vulnerable humans are mandatory to approve these outcomes.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed40    
    Printed0    
    Emailed0    
    PDF Downloaded9    
    Comments [Add]    

Recommend this journal